MICHELENE WITTHUHN: Open Payments
NPI 1740906536 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 15 payments from 9 companies in 2025. Trend: 2023 $65 · 2024 $409 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 2 | $28 |
| PFIZER INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Organon LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: QULIPTA, CAPLYTA, JARDIANCE, Cologuard Collection Kit, PREVNAR 20, BREZTRI, NEXPLANON, MOUNJARO.
Industry payments across NE — which companies pay providers there.
